Shopping Cart
- Remove All
- Your shopping cart is currently empty
JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family. |
In vivo | JPM-OEt (50 mg/kg; i.p.; daily for 30 days) significantly decreases tumor cathepsin B activity[1]. JPM-OEt (50 mg/kg; i.p.; twice daily for 4 weeks) induces tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis[2]. JPM-OEt (50 mg/kg; i.p.; daily from 63 to 98 days) significantly delays tumor burden increase during the first 2 weeks of treatment[3]. |
Molecular Weight | 392.45 |
Formula | C20H28N2O6 |
Cas No. | 262381-84-0 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.